Secondary Logo

Journal Logo

Articles by Adriano Lazzarin

Viro-immunological outcomes after 13-valent pneumococcal vaccination in HIV-1-infected individuals on stable virological suppression

Dell’Acqua, Raffaele; Galli, Laura; Poli, Andrea; More

AIDS. 33(13):1987-1994, November 1, 2019.

Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy

Galli, Laura; Spagnuolo, Vincenzo; Poli, Andrea; More

AIDS. 28(16):2407-2415, October 23rd, 2014.

Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety results

Castagna, Antonella; Spagnuolo, Vincenzo; Galli, Laura; More

AIDS. 28(15):2269-2279, September 24th, 2014.

Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings

Cooper, David A.; Heera, Jayvant; Ive, Prudence; More

AIDS. 28(5):717-725, March 13th, 2014.

Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials

Cohen, Calvin J.; Molina, Jean-Michel; Cassetti, Isabel; More

AIDS. 27(6):939-950, March 27th, 2013.

Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens

Bigoloni, Alba; Gianotti, Nicola; Spagnuolo, Vincenzo; More

AIDS. 26(14):1837-1840, September 10th, 2012.

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience

Nozza, Silvia; Galli, Laura; Visco, Francesca; More

AIDS. 24(6):924-928, March 27th, 2010.

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

Katlama, Christine; Haubrich, Richard; Lalezari, Jacob; More

AIDS. 23(17):2289-2300, November 13th, 2009.

Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies

Canducci, Filippo; Sampaolo, Michela; Marinozzi, Maria Chiara; More

AIDS. 23(4):455-460, February 20th, 2009.

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis

Mussini, Cristina; Manzardo, Christian; Johnson, Margaret; More

AIDS. 22(18):2461-2469, November 30th, 2008.

Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study

Cozzi-Lepri, Alessandro; Phillips, Andrew N; Clotet, Bonaventura; More

AIDS. 22(16):2187-2198, October 18th, 2008.

Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score

Mocroft, Amanda; Ledergerber, Bruno; Zilmer, Kai; More

AIDS. 21(14):1867-1875, September 2007.

The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years

Nelson, Mark R; Katlama, Christine; Montaner, Julio S; More

AIDS. 21(10):1273-1281, June 2007.

Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study)

Castagna, Antonella; Danise, Anna; Menzo, Stefano; More

AIDS. 20(6):795-803, April 4th, 2006.

96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures

Johnson, Margaret; Grinsztejn, Beatriz; Rodriguez, Claudia; More

AIDS. 20(5):711-718, March 21st, 2006.

TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen: a 14-day proof-of-principle trial

Arastéh, Keikawus; Clumeck, Nathan; Pozniak, Anton; More

AIDS. 19(9):943-947, June 10th, 2005.

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

Johnson, Margaret; Grinsztejn, Beatriz; Rodriguez, Claudia; More

AIDS. 19(7):685-694, April 29th, 2005.

Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients

Turriziani, Ombretta; Butera, Ornella; Gianotti, Nicola; More

AIDS. 19(5):473-479, March 25th, 2005.

Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations

Clotet, Bonaventura; Raffi, François; Cooper, David; More

AIDS. 18(8):1137-1146, May 21st, 2004.

Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients

Phillips, Andrew N.; Pradier, Christian; Lazzarin, Adriano; More

AIDS. 15(18):2385-2395, December 7th, 2001.

Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine

Wit, Ferdinand W. N. M.; Wood, Robin; Horban, Andrzej; More

AIDS. 15(18):2423-2429, December 7th, 2001.

The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study

Mocroft, Amanda; Phillips, Andrew N.; Miller, Veronica; More

AIDS. 15(2):201-209, January 26th, 2001.

Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy

Bart, Pierre-Alexandre; Rizzardi, G. Paolo; Tambussi, Giuseppe; More

AIDS. 14(13):1887-1897, September 8th, 2000.

Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication

Cinque, Paola; Vago, Luca; Mengozzi, Manuela; More

AIDS. 12(11):1327-1332, July 30th, 1998.

Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients

Cinque, Paola; Vago, Luca; Dahl, Helena; More

AIDS. 10(9):951-958, 1996.

HIV-related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation

Landonio, Giuseppe; Galli, Massimo; Nosari, Annamaria; More

AIDS. 4(1):29-34, January 1990.

The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters

Rezza, Giovanni; Lazzarin, Adriano; Angarano, Gioacchino; More

Aids. 3(2):87-90, February 1989.

Show: